During the postprandial state, dietary lipid is transported from the intest
ine to peripheral tissues by plasma lipoproteins called chylomicrons. In th
e capillary beds of peripheral tissues, chylomicron triglycerides are lipol
yzed by the enzyme, lipoprotein lipase, allowing the delivery of free fatty
acids to the cells. As a result, this produces a new particle of smaller s
ize and enriched with cholesteryl ester referred to as chylomicron remnants
. These particles are rapidly removed from the blood primarily by the liver
. The liver has a complex chylomicron remnant removal system which is compr
ised of a combination of different mechanisms that include the low-density-
lipoprotein receptor (LDLR) and the LDLR-related-protein (LRP). Furthermore
, it has been suggested that there is a sequestration component whereby chy
lomicron remnants bind to heparan sulfate proteoglycans (HSPG) and/or hepat
ic lipase; this is then followed by transport to one or both of the above r
eceptors for hepatic uptake. Over the years, a major concern has arisen abo
ut the association of chylomicron remnants and coronary heart disease (CHD)
in man. Slow removal of chylomicron remnants, as reflected by a prolonged
postprandial state, is now commonly observed in patients with CHD and those
that have abnormal lipid disorders such as hypertriglyceridemia, familial
hypercholesterolemia, familial combined hyperlipidemia and non-insulin-depe
ndent-diabetes-mellitus. The present review will focus on (a) the details o
f the metabolic pathway (exogenous pathway) that describes the two-step pro
cessing of postprandial lipoproteins, (b) the role of the liver, the recept
ors, and the importance of efficient removal of chylomicron remnants from t
he blood circulation, and (c) the potential atherogenic effects of chylomic
ron remnants on the arterial wall.